He writes about The strain of remaining a medical professional and the distinctive angles he sees during the medical field.Johnson & Johnson (J&J) and Novartis swapped positions from past 12 months’s list to male the 3rd and fourth places, respectively. J&J prescription drug earnings for 2022 did improve sufficient to eclipse the $50 billion mark